CBD and THC are two molecules produced by the same plant, Cannabis sativa, with exactly the same molecular formula: C21H30O2. The difference lies in the way those atoms are assembled. THC activates the brain's CB1 receptor and produces the psychoactive effect of cannabis. CBD, for its part, binds very poorly to that receptor: it does not cause a high.
Everything else follows from that difference in structure. THC is classed as a narcotic in France, CBD is not. Drug tests look for THC, never CBD. And it is the THC level, not the CBD level, that decides whether a product may be sold.
Key points — CBD and THC are isomers: same formula C21H30O2, different structures. THC is a partial agonist of the CB1 receptor, hence its psychoactive effect; CBD has a very low affinity for CB1 and does not get you high. In France, THC is a narcotic; CBD products are permitted if they contain less than 0.3% Δ9-THC. Drug tests target THC: a compliant CBD flower contains traces of it, which can be enough to make them react. The plant mainly produces THCA and CBDA, which heat converts.
Same molecular formula, two architectures
CBD and THC each have 21 carbon atoms, 30 hydrogen atoms and 2 oxygen atoms, for a molar mass of about 314 g/mol. In chemistry, these are called isomers: same building blocks, different assembly plan.
What changes in the molecule
THC is tricyclic: one of its oxygen atoms closes a third ring (a pyran ring) at the centre of the molecule, which makes it fairly rigid and flat.
In CBD, that central ring is not closed. The molecule keeps two free hydroxyl groups (–OH) on its aromatic ring, and its two halves can rotate relative to each other. It therefore does not have the same shape in space.
CBD was isolated as early as 1940 by Roger Adams's team, and its structure established in 1963 by Mechoulam and Shvo. THC was isolated and described in 1964 by Gaoni and Mechoulam.
A kinship that has consequences
In an acidic medium, CBD can cyclise into THC: the reaction has been known since Adams and was revisited in 2020 by Golombek and colleagues. It is a laboratory reaction, which does not happen in a jar of flowers. But it is through this kind of chemistry that certain synthetic cannabinoids, now banned, are made.
The CB1 receptor: why THC gets you high and CBD does not
The CB1 receptor is very abundant in the central nervous system. It is the main target of THC.
THC: a partial agonist of CB1
THC binds to CB1 at very low concentrations, in the nanomolar range, and partially activates it: it is a partial agonist (Pertwee, 2008). This activation is behind the known effects of cannabis: euphoria, altered perception of time, stimulated appetite, but also short-term memory problems, anxiety or paranoid episodes in some people.
CBD: very low affinity for CB1
CBD, for its part, only binds to CB1 at much higher concentrations, in the micromolar range according to the same review. At the scale of ordinary use, it does not activate this receptor. That is why CBD does not get you high: no cannabis intoxication, no high.
In vitro work (Laprairie and colleagues, 2015) describes it as a negative allosteric modulator of CB1: it is thought to bind to a secondary site on the receptor and reduce its response. This is basic research, from which no promise of an effect in humans can be drawn.
Does CBD "tone down" THC?
The idea is everywhere, but the data are contradictory. A 2013 study (Englund and colleagues) observed fewer paranoid symptoms when CBD was given before THC. A randomised double-blind trial by the same team, in 2022, with 46 volunteers and four CBD/THC ratios, found no protective effect. It is a hypothesis, not an established fact.
Dependence and risk profile
In its 2018 critical review report, the WHO expert committee states that CBD does not show, in humans, effects indicative of abuse or dependence potential, unlike THC. That does not make it a harmless product: it is not recommended for minors or for pregnant or breastfeeding women, and calls for medical advice if you are on any treatment.
THCA and CBDA: what the plant really makes
A fresh flower contains very little THC and CBD. The plant produces their acidic precursors, THCA and CBDA, which carry an extra carboxyl group.
Under the effect of heat (and, more slowly, of time and light), that group leaves as CO2: this is decarboxylation. The kinetic study by Wang and colleagues (2016) shows that it is complete within a few tens of minutes above roughly 110 °C, and near-instant during combustion or vaporisation.
The consequence for reading an analysis: a serious laboratory reports total THC, i.e. Δ9-THC + 0.877 × THCA (the coefficient is the ratio of the molar masses). The same logic applies to total CBD. A product showing 0.1% Δ9-THC but 0.5% THCA will exceed 0.3% once heated. That is the line to look at first.
Legal status in France: the 0.3% THC limit
As of September 2026, the situation is as follows.
- THC: on the list of narcotics (arrêté of 22 February 1990, a ministerial order). Using it is an offence under article L3421-1 of the Code de la santé publique (French Public Health Code), punishable by up to one year's imprisonment and a €3,750 fine, with the possibility of a €200 fixed fine (amende forfaitaire).
- CBD: not classed as a narcotic. The CJEU "Kanavape" ruling of 19 November 2020 (C-663/18) held that a Member State could not ban CBD lawfully produced elsewhere in the Union without a public health justification.
- The French framework: the arrêté of 30 December 2021 authorises products derived from authorised hemp varieties, provided their Δ9-THC content does not exceed 0.3%. It banned the sale of raw flowers and leaves; the Conseil d'État (France's supreme administrative court) annulled that ban on 29 December 2022.
The detail is in the full overview of CBD's legal status in France. Always check the official sources: the law changes.
Drug tests and driving: the tests look for THC
No test looks for CBD. Saliva tests target THC, urine tests target its metabolite, THC-COOH. The problem comes from the traces of THC present in compliant products.
What the studies show
- Spindle and colleagues (2020) gave pure CBD to six volunteers: no urine sample was confirmed positive. After vaporising CBD-rich cannabis containing 3.7 mg of THC, several samples were confirmed positive.
- Pacifici and colleagues (2020) had six volunteers smoke a one-gram cigarette of hemp at 0.16% THC. Thirty minutes later, THC was measurable in saliva (5 to 15 ng/mL) and in blood.
What the Code de la route says
Article L235-1 of the Code de la route (French Highway Code) sets no tolerated THC threshold: it is presence that counts, not the driver's condition. Since the law of 9 July 2025, the offence is punishable by three years' imprisonment and a €9,000 fine, with six points taken off the licence. Having consumed a legally sold product is not an automatic defence.
If you drive or are subject to testing, the only consistent choice is not to consume flowers or resins beforehand. The guides CBD and driving and saliva test after CBD go into the waiting times and the uncertainties.
What this changes when you buy
The CBD percentage tells you about the product's concentration. The THC percentage decides whether it is compliant. Both can be checked on a certificate of analysis (COA), which you are entitled to demand from any seller.
- Total THC below 0.3%, calculated with THCA, not just Δ9-THC.
- Total CBD consistent with the type of product. An indoor CBD flower such as Tyson is listed at 19.45%; a resin, which is more concentrated, such as Gorilla Hash, at 48.55%.
- An identified laboratory, a recent date, a batch number that matches the product.
- Be wary of a seller who promises an "effect close to THC", or CBD percentages that are implausible for a flower.
More CBD does not mean "stronger" in the THC sense: there is no intoxication to expect, whatever the percentage. And if you smoke, combustion is harmful to your health, whatever the plant.
Common mistakes
- "No high, so no risk at the wheel." Wrong: the test looks for THC, and a compliant flower contains some.
- "CBD is legal, so every CBD product is." No: it all depends on the THC content and the origin of the hemp.
- "0% Δ9-THC on the label, job done." Look at the THCA: it becomes THC when heated.
- "CBD neutralises THC." A hypothesis not confirmed by the most rigorous trial to date.
Sources
- Arrêté du 30 décembre 2021 portant application de l'article R. 5132-86 du Code de la santé publique — Légifrance
- Conseil d'État, décision du 29 décembre 2022 annulant l'interdiction de vente des fleurs et feuilles de chanvre — conseil-etat.fr
- CJUE, arrêt du 19 novembre 2020, affaire C-663/18 (« Kanavape »)
- Code de la route, article L235-1, as amended by loi n° 2025-622 du 9 juillet 2025; Code de la santé publique, article L3421-1; arrêté du 22 février 1990 fixant la liste des stupéfiants
- WHO, Expert Committee on Drug Dependence, Cannabidiol (CBD) Critical Review Report, 2018
- Adams R. et al., JACS, 1940; Mechoulam R., Shvo Y., Tetrahedron, 1963; Gaoni Y., Mechoulam R., JACS, 1964
- Pertwee R.G., British Journal of Pharmacology, 2008; Laprairie R.B. et al., British Journal of Pharmacology, 2015
- Englund A. et al., Journal of Psychopharmacology, 2013; Englund A. et al., Neuropsychopharmacology, 2022
- Wang M. et al., Cannabis and Cannabinoid Research, 2016; Golombek P. et al., Toxics, 2020
- Spindle T.R. et al., Journal of Analytical Toxicology, 2020; Pacifici R. et al., Clinical Chemistry and Laboratory Medicine, 2020
